Walder Wyss advised UBS Switzerland AG as mandated lead arranger, lender, agent and security agent, while Schellenberg Wittmer acted as Swiss legal counsel to Meeberg Leasing...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as Swiss legal counsel to Mercer on the transaction, while Milbank LLP advised the shareholders of hkp group AG. Mercer has acquired hkp///group....
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as legal counsel to Swiss Life on this transaction. Swiss Life has successfully placed a EUR 500 million dated subordinated bond, first callable...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as counsel to the Joint Lead Managers on the issuance. Sandoz, a global leader in the generics and biosimilars markets successfully placed EUR...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised CorFlow Therapeutics AG on the deal. Kellerhals Carrard advised Broadview Ventures and Panakes Partners. CorFlow Therapeutics AG completed a series B financing round...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Bregal Unternehmerkapital; Bär & Karrer acted for Capvis; Niederer Kraft Frey acted for BSI Software AG. Bregal Unternehmerkapital acquired a majority stake in...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised SkyCell AG on all legal and tax aspects of this transaction. SkyCell AG closed its $116 million Series D financing round which embarked...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised BNP Paribas as Global Coordinator and the banking syndicate with respect to all aspects of Swiss. Barry Callebaut Group, the world’s leading manufacturer...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as legal counsel to Helvetia on this transaction. Helvetia successfully placed a CHF 230 million senior bond with maturity in 2034 and a...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised KLAR Partners on the transaction. KLAR Partners Limited acquired all shares in BÜHLMANN Laboratories AG. BÜHLMANN Laboratories is a Swiss company, located in...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised the funds managed by Perceptive Advisors, LLC. SOPHiA GENETICS SA (NASDQ: SOPH), a Swiss data-driven medicine software company, closed a secured term loan...
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as legal counsel to Swiss Life on this transaction. Swiss Life Holding Ltd. successfully placed three tranches of senior bonds totalling CHF 600...
You must be a Standard 1 Year member to access this content.
